Bill > SB726

This bill modifies regulations around the sale and purchase of drugs containing ephedrine, phenylpropanolamine, or pseudoephedrine (common ingredients in cold medications that can be used to manufacture methamphetamine) by establishing strict limits on how much an individual can buy within specific time periods. Specifically, within a 30-day period, no person can sell or purchase more than 7.2 grams of these drugs; within a 24-hour period, no more than 3.6 grams can be sold or purchased; and within a 12-month period, no more than 61.2 grams can be sold or purchased (previously 43.2 grams). The bill requires these drugs to be sold only from behind a pharmacy counter by a registered pharmacist or technician, and mandates that pharmacies submit sales information to state authorities. Starting October 1, 2025, drug manufacturers must pay monthly fees to the administrator of a real-time electronic pseudoephedrine tracking system. The bill also nullifies any local ordinances with stricter regulations, makes violations a class A misdemeanor, and requires that all sales records be open to law enforcement inspection. The goal of these provisions is to reduce the availability of precursor drugs used in illegal methamphetamine production while maintaining access for legitimate medical purposes.

Health and Social Services

https://www.senate.mo.gov/25info/BTS_Web/Bill.aspx?SessionType=R&BillID=5507348